Clinical Trial Update: Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated vorinostat in combination with gemcitabine and docetaxel for advanced sarcoma; the study has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Vorinostat (vorinostat)

Snippet

Sponsor: Melissa Burgess, MD | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-21